Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting120%
completed240%
recruiting120%
enrolling_by_invitation120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

NCT05295628
enrolling_by_invitation

A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke

NCT07045233
recruitingnot_applicable

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation

NCT04685317
completednot_applicable

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

NCT04149535
completed

Sentinel(TM) Post-Market Registry

NCT02255851

Clinical Trials (5)

Showing 5 of 5 trials
NCT05295628Not Applicable

Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Active Not Recruiting
NCT07045233

A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke

Enrolling By Invitation
NCT04685317Not Applicable

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation

Recruiting
NCT04149535Not Applicable

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

Completed
NCT02255851

Sentinel(TM) Post-Market Registry

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5